These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20870725)

  • 1. The MBT repeats of L3MBTL1 link SET8-mediated p53 methylation at lysine 382 to target gene repression.
    West LE; Roy S; Lachmi-Weiner K; Hayashi R; Shi X; Appella E; Kutateladze TG; Gozani O
    J Biol Chem; 2010 Nov; 285(48):37725-32. PubMed ID: 20870725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1.
    Kalakonda N; Fischle W; Boccuni P; Gurvich N; Hoya-Arias R; Zhao X; Miyata Y; Macgrogan D; Zhang J; Sims JK; Rice JC; Nimer SD
    Oncogene; 2008 Jul; 27(31):4293-304. PubMed ID: 18408754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of p53 function by SET8-mediated methylation at lysine 382.
    Shi X; Kachirskaia I; Yamaguchi H; West LE; Wen H; Wang EW; Dutta S; Appella E; Gozani O
    Mol Cell; 2007 Aug; 27(4):636-46. PubMed ID: 17707234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation-acetylation interplay activates p53 in response to DNA damage.
    Ivanov GS; Ivanova T; Kurash J; Ivanov A; Chuikov S; Gizatullin F; Herrera-Medina EM; Rauscher F; Reinberg D; Barlev NA
    Mol Cell Biol; 2007 Oct; 27(19):6756-69. PubMed ID: 17646389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic methylation of Numb by Set8 regulates its binding to p53 and apoptosis.
    Dhami GK; Liu H; Galka M; Voss C; Wei R; Muranko K; Kaneko T; Cregan SP; Li L; Li SS
    Mol Cell; 2013 May; 50(4):565-76. PubMed ID: 23706821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond histone methyl-lysine binding: how malignant brain tumor (MBT) protein L3MBTL1 impacts chromatin structure.
    Trojer P; Reinberg D
    Cell Cycle; 2008 Mar; 7(5):578-85. PubMed ID: 18256536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for lower lysine methylation state-specific readout by MBT repeats of L3MBTL1 and an engineered PHD finger.
    Li H; Fischle W; Wang W; Duncan EM; Liang L; Murakami-Ishibe S; Allis CD; Patel DJ
    Mol Cell; 2007 Nov; 28(4):677-91. PubMed ID: 18042461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation.
    Abbas T; Shibata E; Park J; Jha S; Karnani N; Dutta A
    Mol Cell; 2010 Oct; 40(1):9-21. PubMed ID: 20932471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of p53 activity by Smyd2-mediated methylation.
    Huang J; Perez-Burgos L; Placek BJ; Sengupta R; Richter M; Dorsey JA; Kubicek S; Opravil S; Jenuwein T; Berger SL
    Nature; 2006 Nov; 444(7119):629-32. PubMed ID: 17108971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L3MBTL1, a histone-methylation-dependent chromatin lock.
    Trojer P; Li G; Sims RJ; Vaquero A; Kalakonda N; Boccuni P; Lee D; Erdjument-Bromage H; Tempst P; Nimer SD; Wang YH; Reinberg D
    Cell; 2007 Jun; 129(5):915-28. PubMed ID: 17540172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of p53 activity through lysine methylation.
    Chuikov S; Kurash JK; Wilson JR; Xiao B; Justin N; Ivanov GS; McKinney K; Tempst P; Prives C; Gamblin SJ; Barlev NA; Reinberg D
    Nature; 2004 Nov; 432(7015):353-60. PubMed ID: 15525938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L3MBTL1 polycomb protein, a candidate tumor suppressor in del(20q12) myeloid disorders, is essential for genome stability.
    Gurvich N; Perna F; Farina A; Voza F; Menendez S; Hurwitz J; Nimer SD
    Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22552-7. PubMed ID: 21149733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L3MBTL1 recognition of mono- and dimethylated histones.
    Min J; Allali-Hassani A; Nady N; Qi C; Ouyang H; Liu Y; MacKenzie F; Vedadi M; Arrowsmith CH
    Nat Struct Mol Biol; 2007 Dec; 14(12):1229-30. PubMed ID: 18026117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p21/CDKN1A mediates negative regulation of transcription by p53.
    Löhr K; Möritz C; Contente A; Dobbelstein M
    J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SET8 H4K20 protein lysine methyltransferase has a long recognition sequence covering seven amino acid residues.
    Kudithipudi S; Dhayalan A; Kebede AF; Jeltsch A
    Biochimie; 2012 Nov; 94(11):2212-8. PubMed ID: 22583696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin protein L3MBTL1 is dispensable for development and tumor suppression in mice.
    Qin J; Van Buren D; Huang HS; Zhong L; Mostoslavsky R; Akbarian S; Hock H
    J Biol Chem; 2010 Sep; 285(36):27767-75. PubMed ID: 20592034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Product specificity and mechanism of protein lysine methyltransferases: insights from the histone lysine methyltransferase SET8.
    Zhang X; Bruice TC
    Biochemistry; 2008 Jun; 47(25):6671-7. PubMed ID: 18512960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human EHMT2/G9a activates p53 through methylation-independent mechanism.
    Rada M; Vasileva E; Lezina L; Marouco D; Antonov AV; Macip S; Melino G; Barlev NA
    Oncogene; 2017 Feb; 36(7):922-932. PubMed ID: 27452519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone H4 lysine 20 monomethyl mark, set by PR-Set7 and stabilized by L(3)mbt, is necessary for proper interphase chromatin organization.
    Sakaguchi A; Joyce E; Aoki T; Schedl P; Steward R
    PLoS One; 2012; 7(9):e45321. PubMed ID: 23024815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural studies of a four-MBT repeat protein MBTD1.
    Eryilmaz J; Pan P; Amaya MF; Allali-Hassani A; Dong A; Adams-Cioaba MA; Mackenzie F; Vedadi M; Min J
    PLoS One; 2009 Oct; 4(10):e7274. PubMed ID: 19841675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.